Recursion Pharmaceuticals
RXRX
#4280
Rank
NZ$3.41 B
Marketcap
$11.90
Share price
2.45%
Change (1 day)
28.31%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2023 (TTM): -$2.27

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.31. In 2022 the company made an earnings per share (EPS) of -$2.30 a decrease over its 2021 EPS that were of -$1.96.

EPS history for Recursion Pharmaceuticals from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.27-1.3%
2022-$2.3017.39%
2021-$1.9650.85%
2020-$1.30